C002
טבע תעשיות פרמצבטיות בע"מ
2
Public
TEVA- PHARMACEUTICAL INDUSTRIES LTD.
2529
Corporation no:
520013954
Stock Exchange/Market:
טבע
310
380
P.O.B
3190
,
Petach Tikva
49131
,
,
Tel:
03-9267297
,
03-9267281
Fax:
03-9267429
E.mail address:
DORIT@TEVA.CO.IL
Date of transmission:
27/10/2005
Time of broadcast:
19:01
18:19:43
Reference:
2005-02-077575
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA AND IVAX SHAREHOLDERS APPROVE PENDING MERGER
Shareholders_Approve_Pending_Merger_E_Final_combined271005_isa.pdf
Please find attached a press release and its non-binding hebrew translation, provided for convenience purposes only, reporting on the results of today's shareholder meetings of Teva and Ivax.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure:
04/09/2005
Name of the Signatory
:
Suesskind Dan
,
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
Basel
Telephone:
02-5892840
,
Facsimile:
02-5892839
,
E-mail:
dan.suesskind@teva.co.il